EUVIMEDEUVIMED entdecken
Klinische StudieMultizentrische StudieOpen Access · CC BY 4.0

Clinical Results of Mentor MemoryGel Xtra Breast Implants From the GLOW Clinical Trial

Amy Alderman, David Caplin, Dennis C Hammond, Alexandra Keane, Jay Turetzky iD, William J Kane

Aesthetic Surgery Journal · 16.11.2023 · 43 (12) · NP1021-NP1032

DOI: 10.1093/asj/sjad272 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Aesthetic Surgery Journal, online erschienen am 23.08.2023. Verfasst von Amy Alderman und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Breast Implantation, Breast Implants, Contracture. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mentor Worldwide, LLC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mentor MemoryGel Xtra breast implants (Mentor Worldwide LLC, Irvine, CA) were designed to maintain the soft, natural feel of MemoryGel implants while increasing fullness and projection and minimizing wrinkling, rippling, and related complications through optimization of shell gel-fill.

Objectives

To measure 3-year safety and effectiveness of MemoryGel Xtra breast implants in the Mentor MemoryGel and MemoryShape Combined Cohort Clinical Study.

Methods

Participants were implanted with MemoryGel Xtra breast implants in a prospective, multicenter clinical trial. Rates of complications and reoperations were analyzed to assess device safety and BREAST-Q was employed to assess device effectiveness.

Results

Two hundred eighty-seven females receiving MemoryGel Xtra breast implants were enrolled. Complication rates in the primary augmentation cohort included rates of 1.5% for implant-related reoperation, 2.3% for explantation, and 1.5% for Baker grade III or IV capsular contracture. For the revisional augmentation cohort, these rates were 2.8% for implant-related reoperation, 4.3% for explantation, and 3.0% for capsular contracture. For the primary reconstruction cohort, these rates were 12.0% for implant-related reoperation, 12.3% for explantation, and 7.3% for capsular contracture. For the revisional reconstruction cohort, these rates were 7.1% for capsular contracture, with zero implant-related reoperations or explantations. There were no reports of infection or implant malposition or displacement in any of these cohorts. Each cohort showed significantly improved satisfaction with breasts and psychosocial and sexual well-being at 1 year following the primary procedure.

Conclusions

These data are consistent with legacy clinical data for MemoryGel and provide the first published safety and effectiveness data regarding the use of MemoryGel Xtra breast implants for breast augmentation and reconstruction. Level of Evidence: 4

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast ImplantationBreast ImplantsContractureFemaleHumansFollow-Up StudiesPostoperative ComplicationsProspective StudiesProsthesis DesignReoperationSilicone Gels

Substanzen

Silicone Gels

Autor:innen und Institutionen

ORCID-Profile: Jay Turetzky

Förderung

  • Mentor Worldwide, LLC

Zitieren

APA

Alderman, A., Caplin, D., Hammond, D. C., Keane, A., Turetzky, J., & Kane, W. J. (2023). Clinical Results of Mentor MemoryGel Xtra Breast Implants From the GLOW Clinical Trial. Aesthetic Surgery Journal, 43(12), NP1021-NP1032. https://doi.org/10.1093/asj/sjad272

Vancouver

Alderman A, Caplin D, Hammond DC, Keane A, Turetzky J, Kane WJ. Clinical Results of Mentor MemoryGel Xtra Breast Implants From the GLOW Clinical Trial. Aesthetic Surgery Journal. 2023;43(12):NP1021-NP1032. doi:10.1093/asj/sjad272

BibTeX
@article{Alderman2023,
  author = {Alderman, Amy and Caplin, David and Hammond, Dennis C and Keane, Alexandra and Turetzky, Jay and Kane, William J},
  title = {Clinical Results of Mentor MemoryGel Xtra Breast Implants From the GLOW Clinical Trial},
  journal = {Aesthetic Surgery Journal},
  year = {2023},
  volume = {43},
  number = {12},
  pages = {NP1021--NP1032},
  doi = {10.1093/asj/sjad272}
}
Kostenlos starten →